Victor Sung, M.D., director of the Division of Movement Disorders in the University of Alabama at Birmingham Department of Neurology and director of the UAB Huntington’s Disease Clinic, reacted to the ...

Bryce Vissel does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

A gene therapy injected into patients’ brains slowed progression of the disease by 75 percent, preliminary findings reported. By Dana G. Smith Preliminary results from a small clinical trial to treat ...

Am J Health Syst Pharm. 2007;64(20):S13-S20. The use of alvimopan for the treatment of OBD was explored in several Phase II and Phase III studies. One Phase III randomized, placebo-controlled study ...

ROANOKE, Va. (WDBJ) - A growing number of people in Central Virginia are being diagnosed with Alpha-Gal Syndrome. It’s an allergy caused by tick bites that makes eating—or even being near—meat or ...

1 Department of Neurology, Xiangtan Central Hospital (The Affiliated Hospital of Hunan University), Xiangtan, Hunan, China 2 Medical Department, Xiangtan Central Hospital (The Affiliated Hospital of ...

Shawn Connolly, a former skateboarding professional, follows the directions of Nicholas B. Galifianakis, MD, while testing a deep brain stimulation treatment for Parkinson’s disease. Photo by Maurice ...

MISSION VIEJO, Calif. (KABC) -- It's being called a potential game-changer in fighting certain types of cancer and it uses highly-focused soundwaves. For destroying tumors, histotripsy offers many ...

A “bigger stomach” and bloating are commonly reported side effects of a hysterectomy, with many possible causes, including post-surgical inflammation, gas, and hormonal changes related to uterus ...

Words can certainly hurt—but so can the absence of them. If you’ve ever had a partner pretend you don’t exist mid-argument or stop talking until you take all the blame, you understand what we’re ...

Aug 20 (Reuters) - The U.S. Food and Drug Administration on Tuesday approved Johnson & Johnson's (JNJ.N), opens new tab chemotherapy-free combination treatment for a type of non-small cell lung cancer ...